Veteran teachers are no strangers to the disruptions caused by new technologies. AI is the latest in a long line of ...

The FDA approved Nubeqa for metastatic castration-sensitive prostate cancer based on significantly improved radiographic ...

How the co-design of a practical guide to support nursing practice related to long Covid can enhance patient safety and ...

Meta’s shift to AI-driven assessments for product updates aims to speed up launches but raises concerns about reduced human ...

Several AON physicians and leaders shared new cancer research at one of oncology’s most influential gatheringsFORT MYERS, Fla ...

AN2 Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. AN2 has a pipeline of boron ...

Safety and Efficacy of Osimertinib in Patients With Non–Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-Analysis ...

today announced that the company will present a poster highlighting the preclinical activity of epetraborole against M. abscessus on Thursday, May 29, 2025 at the Nontuberculous Mycobacteria ...

Nebius is well-positioned with valuable side businesses and asymmetric upside potential. Click here to find out why NBIS ...

Poster Presentation (213/3544): Circulating tumor ... data from unstructured EHRs into a structured format suitable for analysis. Tempus utilized a two-stage LLM system to abstract critical ...

This paper employs a meta-regression analysis of 473 estimates from 15 studies to take stock of the empirical literature on Chinese aid effectiveness. After accommodating publication selection bias, ...